Spiral is pleased to announce our involvement in another incredibly exciting trial, aimed at producing effective Covid-19 treatments for critical care patients.

When it comes to clinical trials, we look to continue to make a difference around the world with our savvy software platform. We speak to Sharon Micallef, a trial project manager from The George Institute of Global Health, about her experience working with the team at Spiral to produce a database for her latest study.

REMAP-CAP an application in Spiral’s study manifest, has recently been used in a collaborative clinical trial that focused on identifying effective treatments for critically ill Covid-19 patients.

Meet Emma. As a Project Manager, Emma wears many hats here at Spiral; applying her wide range of skills to our incredibly agile environment.

Therapeutic Anticoagulation in Non-Critically Ill Patients with Covid-19 - a recently published report discusses a trial that employed #REMAP-CAP as one of its three collaborating platforms.

Meet Jess. Although officially a project manager here at Spiral, we have a few other names for how Jess applies herself across our collective outcomes.

With many schools around the world in lockdown, students are expected to learn from home with online lessons. But what happens when a family doesn’t have a device? Or just one device to share between children?

Stew’s been a Developer for more than 30 years, but he says that working with us at Spiral has been some of the most meaningful.

Covid-19 brought immense challenges to everyone in 2020, and it brought us our greatest challenge ever: adapting our Spinnaker platform to manage the world’s most complex clinical trial – a trial that tackled Covid-19 head-on.

A small software company in New Zealand, Spiral, helped to create a ground-breaking clinical trial in unprecedented timeframes. One that had a real, human benefit for COVID-19 sufferers around the world.